Journal article icon

Journal article

Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies

Abstract:
Abstract Most neurodegenerative diseases lack definitive diagnostic tests, and the identification of easily accessible and reliable biomarkers remains a critical unmet need. Since tau protein is highly expressed in skin of tauopathies patients, we aimed to exploit the ultrasensitive seeding activity assay (SAA) to assess tau seeding activity in skin of patients with tauopathies. In this multicentric, case-control study, patients with tauopathies and synucleinopathies were consecutively recruited and sex-matched to healthy controls (HC). Subjects underwent a double 3 mm skin biopsy in cervical area and ankle. Skin tau-SAA, using TauK18 and TauK19 as reaction substrates for 4R and 3R isoforms, seeding score, clinical scales, biochemical and morphological characterization of SAA end-products were evaluated. We analyzed 58 subjects: 24 tauopathies (18 progressive supranuclear palsy, PSP, and 6 corticobasal degeneration, CBD), 20 synucleinopathies (14 Parkinson’s disease, PD, and 6 multiple system atrophy, MSA), and 14 HC. PSP and CBD showed higher tau seeding activity at both anatomical sites. A greater sensitivity of 4R-SAA than 3R-SAA was observed. 4R tau-SAA identified tauopathies with 71% sensitivity and 93% specificity. Accuracy was higher for PSP than CBD: PSP vs HC / PD (AUC 0.825), while CBD vs HC / PD (AUC 0.797), and PSP vs MSA (AU 0.778). SAA end-products showed differences in biochemical and morphological characterization according to the anatomical site. Skin tau-SAA identifies tauopathies with good accuracy and can be used to implement the in-vivo clinical diagnosis of patients with neurodegenerative diseases. Further characterization of peripheral tau seed in skin may elucidate the structure of tau deposits in brain
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1038/s41531-024-00728-9
Publication website:
https://boris.unibe.ch/197862/1/s41531-024-00728-9.pdf

Authors

More by this author
Role:
Author
ORCID:
0009-0007-8422-4552
More by this author
Role:
Author
ORCID:
0000-0002-8419-277X
More by this author
Role:
Author
ORCID:
0000-0002-2015-5857
More by this author
Role:
Author
ORCID:
0000-0001-7242-4986
More by this author
Role:
Author
ORCID:
0000-0002-4563-386X


Publisher:
Nature Research
Journal:
npj Parkinson's Disease More from this journal
Volume:
10
Issue:
1
Pages:
116-116
Article number:
116
Publication date:
2024-06-15
DOI:
EISSN:
2373-8057
ISSN:
2373-8057


Language:
English
Keywords:
Pubs id:
2436564
Local pid:
pubs:2436564
Source identifiers:
W4399703389
Deposit date:
2026-06-23
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP